We assessed a cohort of 78 archived fixed primary, treatment naïve, human breast tumour samples for co‐expression between ALDH1A3 and tPA, uPA, and PAI‐2 (Table S3, tumour pathology and clinical details summarized). This evidence concerns the gene SERPINB2 and neoplasm.